The insurer shrank its plan footprint for 2025 in a bid to improve margins. Now, Humana is giving market watchers loose guidance into how that reduction could affect its enrollment along with second quarter results.| Healthcare Dive
The transaction exits Cigna from a sector that’s been a huge source of growth for insurers but has seen its earnings potential shrink.| Healthcare Dive
The CMS proposed a 0.2% dip in MA rates. However, analysts said regulators will likely improve the payment rate in the final notice.| Healthcare Dive
Despite the uncertainty, the insurer reaffirmed its earnings outlook for 2025.| Healthcare Dive
The insurer on Wednesday joined its peers in slamming proposed MA payment rates as insufficient given the dogged increase in medical costs.| Healthcare Dive
The health insurer sees Medicare Advantage as an area for future growth, despite selling the division for $3.7 billion. Cigna’s CEO called the sale a “win-win” on a call with investors Friday.| Healthcare Dive
On the insurer’s earnings call, analysts peppered Centene with questions about its Medicare Advantage business until its CFO attempted to change the subject.| Healthcare Dive
Because of the final rates for next year, Humana will have to enact “larger benefit reductions to achieve stable margins,” its CFO told investors.| Healthcare Dive
The big question coming out of the health insurance earnings season is how much elevated utilization among seniors is carrying over into 2024.| Healthcare Dive